Flett A, Cebula A, Nicholas Z, Adam R, et al. Rationale and study protocol for the BRITISH randomised trial (Using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with Non-Ischaemic Cardiomyopathy and Am Heart J 2023 Sep 28:S0002-8703(23)00281-8. doi: 10.1016/j.ahj.2023.
PMID: 37777041